![](https://d3ilqtpdwi981i.cloudfront.net/e7Gl8nWpfIeKr1wLPRQ7k4oz6tw=/0x0:114x147/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/75/19/16/751916f3-9ef5-4fed-949c-2664a2ec114c/CBC5.gif)
Article
Health Care Resource Utilization and Costs for Metastatic Breast Cancer Patients Newly Treated with Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Agents
Clinical Breast Cancer
(2021)
Disciplines
Publication Date
2021
Citation Information
Reshma Mahtani, Nina Oestreicher, Deepa Lalla, Augustina Ogbonnaya, et al.. "Health Care Resource Utilization and Costs for Metastatic Breast Cancer Patients Newly Treated with Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Agents" Clinical Breast Cancer (2021) Available at: http://works.bepress.com/reshma-mahtani/100/